Table 4.
Control group (n = 843) | HBcAb+ organ recipients (n = 25) | P-value | |
---|---|---|---|
Deaths, n (%) | 232 (28%) | 6 (24%) | 0.82b |
Transplant to death, years, median (range) | 1.5 (1–12.8) | 0.09 (0.01–0.60) | 0.04a |
Transplant to death, years, mean ± SD | 2.8 ± 3.2 | 0.17 ± 0.22 | |
Cause of death, n (%) | |||
Sepsis/multi-organ failure | 66 (28%) | 4 (67%) | |
Non-liver cancers | 18 (8%) | ||
Recurrent liver cancer | 8 (3%) | ||
Graft failure | 40 (17%) | ||
Cardiac or stroke | 27 (12%) | 1 (17%) | |
Pneumonia | 7 (3%) | ||
Intraoperative death | 9 (4%) | ||
Unnatural death | 6 (3%) | ||
Other | 51 (22%) | 1 (17%) |
Unpaired t-test, two-tailed P-value.
Fisher's exact test, two-tailed P-value.
HBcAb+, hepatitis B core antibody-positive; SD, standard deviation.